Evofem Biosciences (EVFM) Short Interest Ratio & Short Volume → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free EVFM Stock Alerts $0.01 0.00 (-4.70%) (As of 03:55 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaSustainability Evofem Biosciences Short Interest DataCurrent Short Volume8,680,000 sharesPrevious Short Volume10,990,000 sharesChange Vs. Previous Month-21.02%Dollar Volume Sold Short$6.34 millionShort Interest Ratio / Days to Cover0.3Last Record DateJuly 31, 2022Outstanding Shares53,960,000 sharesFloat Size37,920,000 sharesShort Percent of Float22.89%Today's Trading Volume178,028 sharesAverage Trading Volume781,934 sharesToday's Volume Vs. Average23% Short Selling Evofem Biosciences ? Sign up to receive the latest short interest report for Evofem Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEVFM Short Interest Over TimeEVFM Days to Cover Over TimeEVFM Percentage of Float Shorted Over Time Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. Evofem Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20228,680,000 shares $6.34 million -21.0%22.9%0.3 $0.73 7/15/202210,990,000 shares $9.65 million -38.3%29.0%0.4 $0.88 6/30/202217,820,000 shares $20.14 million +744.6%51.9%0.7 $1.13 6/15/20222,110,000 shares $623,083.00 +6.0%17.1%0.6 $0.30 5/31/20221,990,000 shares $716,400.00 +64.5%15.9%1.2 $0.36 5/15/20221,210,000 shares $1.38 million +1.7%9.7%1.8 $1.14 Get the Latest News and Ratings for EVFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evofem Biosciences and its competitors with MarketBeat's FREE daily newsletter. 4/30/20221,190,000 shares $3.14 million -93.3%N/A5 $2.64 4/15/202217,790,000 shares $4.02 million +2.8%N/A6.5 $0.23 3/31/202217,310,000 shares $5.89 million -8.2%N/A4.6 $0.34 3/15/202218,850,000 shares $6.97 million -8.0%N/A5 $0.37 2/28/202220,480,000 shares $9.90 million -20.1%N/A5.1 $0.48 2/15/202225,640,000 shares $11.00 million -1.0%N/A6.5 $0.43 1/31/202225,910,000 shares $11.71 million -3.3%N/A6 $0.45 1/15/202226,780,000 shares $10.98 million +5.4%N/A6.1 $0.41 12/31/202125,420,000 shares $9.56 million +3.4%N/A8 $0.38 12/15/202124,590,000 shares $9.34 million +0.4%16.1%7.7 $0.38 11/30/202124,490,000 shares $10.87 million -8.2%N/A9 $0.44 11/15/202126,670,000 shares $17.74 million -1.5%N/A8.4 $0.67 10/29/202127,080,000 shares $18.62 million -1.7%N/A8.4 $0.69 10/15/202127,550,000 shares $19.09 million -0.7%18.1%8 $0.69 9/30/202127,740,000 shares $20.50 million -2.3%18.2%7.4 $0.74 9/15/202128,390,000 shares $22.43 million +5.6%18.6%6.5 $0.79 8/31/202126,880,000 shares $23.84 million -3.4%17.6%3.5 $0.89 8/13/202127,820,000 shares $19.78 million -1.5%18.2%2.8 $0.71 7/30/202128,240,000 shares $24.29 million +0.6%18.8%2.3 $0.86 7/15/202128,070,000 shares $25.82 million -2.3%18.9%2.3 $0.92 6/30/202128,720,000 shares $32.45 million +15.3%19.3%2.4 $1.13 6/15/202124,900,000 shares $30.13 million +130.1%16.7%2.1 $1.21 5/28/202110,820,000 shares $9.31 million -5.5%N/A1.2 $0.86 5/14/202111,450,000 shares $13.97 million -5.2%N/A1.6 $1.22 4/30/202112,080,000 shares $17.64 million +0.1%N/A2.5 $1.46 4/15/202112,070,000 shares $19.79 million +30.8%N/A0 $1.64 3/31/20219,230,000 shares $15.97 million +3.4%N/A1.9 $1.73 3/15/20218,930,000 shares $25.54 million -5.1%N/A2.1 $2.86 2/26/20219,410,000 shares $37.73 million -0.3%N/A2.3 $4.01 2/12/20219,440,000 shares $37.76 million -0.7%N/A2.5 $4.00 1/29/20219,510,000 shares $25.20 million -8.6%N/A3.2 $2.65 1/15/202110,400,000 shares $27.66 million -11.0%N/A4.2 $2.66 12/31/202011,690,000 shares $28.41 million +22.2%N/A5 $2.43 12/15/20209,570,000 shares $20.38 million +32.0%N/A4 $2.13Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. EVFM Short Interest - Frequently Asked Questions What is Evofem Biosciences' current short interest? Short interest is the volume of Evofem Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 8,680,000 shares of EVFM short. 22.89% of Evofem Biosciences' shares are currently sold short. Learn More on Evofem Biosciences' current short interest. What is a good short interest percentage for Evofem Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.89% of Evofem Biosciences' floating shares are currently sold short. Is Evofem Biosciences' short interest increasing or decreasing? Evofem Biosciences saw a decrease in short interest in July. As of July 31st, there was short interest totaling 8,680,000 shares, a decrease of 21.0% from the previous total of 10,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Evofem Biosciences' float size? Evofem Biosciences currently has issued a total of 53,960,000 shares. Some of Evofem Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Evofem Biosciences currently has a public float of 37,920,000 shares. How does Evofem Biosciences' short interest compare to its competitors? 22.89% of Evofem Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Evofem Biosciences: SciSparc Ltd. (21.38%), Neptune Wellness Solutions Inc (0.54%), Evelo Biosciences, Inc. (2.11%), Biodexa Pharmaceuticals Plc (14.70%), Aditxt, Inc. (10.83%), Sunshine Biopharma, Inc. (7.32%), China SXT Pharmaceuticals, Inc. (11.61%), Comera Life Sciences Holdings, Inc. (2.38%), Allarity Therapeutics, Inc. (24.95%), Aptevo Therapeutics Inc. (9.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: KLA Co. ($2.87 billion), Lucid Group, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.08 billion), Coinbase Global, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.85 billion), Chesapeake Energy Co. ($1.81 billion), Rivian Automotive, Inc. ($1.64 billion), Lumen Technologies, Inc. ($1.61 billion), Plug Power Inc. ($1.50 billion), and Generac Holdings Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short Evofem Biosciences stock? Short selling EVFM is an investing strategy that aims to generate trading profit from Evofem Biosciences as its price is falling. EVFM shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evofem Biosciences? A short squeeze for Evofem Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EVFM, which in turn drives the price of the stock up even further. How often is Evofem Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVFM, twice per month. The most recent reporting period available is July, 31 2022. More Short Interest Resources from MarketBeat Related Companies: SciSparc Short Interest Neptune Wellness Solutions Short Interest Evelo Biosciences Short Interest Biodexa Pharmaceuticals Short Interest Aditxt Short Interest Sunshine Biopharma Short Interest China SXT Pharmaceuticals Short Interest Comera Life Sciences Short Interest Allarity Therapeutics Short Interest Aptevo Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVFM) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour Money is Not SafeAmerican Alternative